Suvoda has unveiled the electronic clinical outcome assessments (eCOA) design toolkit, as the solution moves to the Early Adopter programme’s second phase.
This launch is part of the company’s single platform rollout.
Go deeper with GlobalData
The toolkit is created to integrate smoothly with Suvoda IRT and eConsent, and also address the historical inadequacies that still impact eCOA.
These inefficiencies include gaps in the quality of complete delivery and execution, time consuming translations, localisation processes, and logistics linked to the management of the device.
The eCOA solution of the company incorporates feedback from its customers and comprises updated processes in four crucial areas vital for successful eCOA deployment, as it enters the next phase of the programme.
Suvoda eCOA offers a simple, configuration-based toolkit, which can streamline and expedite the setting up and delivery of eCOA.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIt contains a domain-specific language and creation tool that is custom-made for eCOA questionnaires.
With established processes for clinical trial supply chain and data management, Suvoda eCOA will significantly enhance the capturing of data on a real-time basis and streamline device logistics for international trial sites, sponsors, and patients.
Suvoda handles mission-critical matters in real-time, leveraging the worldwide capabilities of its devices and sites.
Coupled with the company’s IRT solution on a single platform and eConsent, eCOA guarantees a simplified approach by lowering the number of incorporations needed for a trial.
Suvoda scientific services vice-president Jill Platko said: “eCOA is not a new concept, yet the full promise of this eClinical technology has yet to be realised by sponsors and CROs, and most importantly, clinical trial participants.
“In support of Suvoda’s mission to enhance the clinical trial process, Suvoda did not want to simply offer another eCOA solution. But instead, wanted to dive into the gaps that make current eCOA implementations so challenging.”
In May this year, the company announced the availability of eConsent as part of its unified platform, offering a simplified solution that allows trial teams more electronic control over the consent process.
